Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) over five years over Washington's request for confidential data.
The decision became public after a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "skewed".
A government spokesman has since explained that the US was seeking genetic material for scientific study and commercial purposes while was not willing to share the resulting advantages from any future treatments.
"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for more negotiations to find a agreement acceptable to all parties so the nation's critical HIV treatment initiative can continue.
Wider Context
This rejection follows a comparable case in Kenya, where a court halted a similar deal with the US after concerns were raised about the safety of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump stated its spending was "wasteful" and his government was pursuing direct bilateral deals to boost transparency and accountability.
Based on statements, Sixteen African countries have to date agreed to these new health pacts, constituting over $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," he stated.
"Put simply, our nation would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our population should a new health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining systems previously set up through the global health agency.
Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with future pandemics.
"This mechanism is intended to ensure that when a country provides its samples, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the capability to develop them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.
"We are open to further dialogue with our US partners on how subsequent collaboration might be structured in a manner that respects the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but suggested that talks must proceed since a large portion of the country's HIV programmes were funded by international support.
"If technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it said.
The situation underscores the ongoing tensions between receiving crucial international aid and protecting local interests in an increasingly interconnected world.